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ABSTRACT
Switching between replicative and translesion syn-
thesis (TLS) DNA polymerases are crucial events for
the completion of genomic DNA synthesis when the
replication machinery encounters lesions in the DNA
template. In eukaryotes, the translesional DNA poly-
merase  (Pol) plays a central role for accurate by-
pass of cyclobutane pyrimidine dimers, the predom-
inant DNA lesions induced by ultraviolet irradiation.
Pol deficiency is responsible for a variant form of
the Xeroderma pigmentosum (XPV) syndrome, char-
acterized by a predisposition to skin cancer. Here,
we show that the FF483–484 amino acids in the hu-
man Pol (designated F1 motif) are necessary for
the interaction of this TLS polymerase with POLD2,
the B subunit of the replicative DNA polymerase ,
both in vitro and in vivo. Mutating this motif im-
pairs Pol function in the bypass of both an N-2-
acetylaminofluorene adduct and a TT-CPD lesion in
cellular extracts. By complementing XPV cells with
different forms of Pol, we show that the F1 motif
contributes to the progression of DNA synthesis and
to the cell survival after UV irradiation. We propose
that the integrity of the F1 motif of Pol, necessary
for the Pol/POLD2 interaction, is required for the
establishment of an efficient TLS complex.
INTRODUCTION
Lesions that are continuously formed on cellular DNA
upon exposure to genotoxic agents impede the progres-
sion of the replicative DNA polymerases. One DNA dam-
age response pathway that overcomes replication arrests
is translesion synthesis (TLS), in which specialized DNA
polymerases allow DNA synthesis along damaged tem-
plates, albeit at the cost of reduced fidelity.
The current model for TLS proposes that this multi-step
process involves several DNA polymerase switches. In a first
step, PCNA, the processivity factor of the replicative poly-
merases, located at stalled replication forks is monoubiq-
uitinated by the Rad18 ubiquitin ligase (1,2). This post-
translational modification promotes the recruitment of Y-
family TLS polymerases (Pol, Pol, Pol and Rev1) by in-
creasing their affinity for PCNA (3–8) and their residence
time at sites of DNA damage (9). For most lesions, the
bypass is then carried out by a two-polymerase reaction
in which insertion of a nucleotide opposite the damage by
a particular DNA polymerase is followed by extension by
another DNA polymerase (10–12). Pol , a B-family DNA
polymerase, plays this extender role in a process mediated
by Rev1, which interacts both with the Rev7 subunit of Pol
and with each of the other Y-family polymerases. Accord-
ingly, recent structural studies provide evidence that Rev1,
Pol and Pol DNA polymerases cooperate within a mega-
translesion polymerase complex (13,14).
Once the lesion bypass is fully completed, the primer
terminus is taken over by high-fidelity polymerases of the
replicative machinery. It has been shown that the B and
C subunits of the replicative DNA polymerase  (human
POLD2 (p50) and POLD3 (p66) or their yeast counter-
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parts Pol31 and Pol32) are also functional components of
Pol (15–17). This observation has led to the proposal that
the exchange of the Pol and Pol catalytic subunits at
the lesion site might occur on a pre-assembled complex of
POLD2 and POLD3 proteins bound to PCNA (16). More
recently, it has been reported that purified Pol31 and Pol32
can form a complex with the TLS polymerase Rev1 in yeast
(18).
Loss of Pol in Xeroderma pigmentosum variant (XPV)
individuals results in a strong susceptibility to sunlight-
induced skin cancers, due to the activation of an error-prone
TLS pathway. Pol has a remarkable ability to perform fast
and accurate bypass across a cis-syn cyclobutane thymine
dimer (TT-CPD) in vitro (19–21) and in vivo (22). Bypass
of this particular lesion may thus represent a special case
in the TLS model, as Pol is able to perform both the inser-
tion and extension steps without the help of other TLS poly-
merases (23). Several domains of Pol have been shown to
be important for its function in TLS: the PIP and the UBZ
domains are involved in the interaction with PCNA and its
monoubiquitinated form, respectively (3–5,24). The activ-
ity of Pol is also regulated by post-translational modifica-
tions such as monoubiquitination (25) or phosphorylation
at S601 (26), S587 and T617 (27). In this paper, we investi-
gated whether Pol could directly interact with Pol. Only
POLD2, the B-subunit of Pol, was found to bind to Pol
in a two-hybrid experiment and this interaction was further
confirmed in a pull-down assay. Mutation of the FF483–484
motif of Pol (designated F1 motif) involved in the interac-
tion with POLD2 reduces the Pol ability to perform TLS
catalyzed by cellular extracts in vitro and to rescue the UV
sensitivity of XPV fibroblasts. Taken together, our results
disclose a novel role for the F1 motif of Pol and provide
the first evidence for a direct interaction of this TLS poly-
merase with the replicative polymerase . We propose that
this interaction facilitates the access of Pol to the DNA
substrate.
MATERIALS AND METHODS
Cell lines and plasmids
Cells were grown at 37◦C in Dulbecco’s modified Eagle’s
medium supplemented with 5% fetal bovine serum (Euro-
bio) and gentamicin (Sigma). MRC5-V1 cells (called MRC5
in this paper) are SV40-transformed normal human lung
fibroblasts (28). The XP30RO cell line (SV40-transformed
XPV human fibroblasts) has a homozygous deletion in
the Pol gene resulting in a truncated protein of only 42
amino acids (29). XP30RO cell lines expressing wild type
(WT) or mutated forms of Pol were generated by transfec-
tion with a pcDNA3.1/zeo(-) plasmid harboring the cor-
responding Pol sequence; transfected cells were thereafter
selected with 100 g/ml of zeocin (Invitrogen). ECFP-Pol
and EYFP-Pol constructs have been described elsewhere
(30). Mutations in the coding sequence of Pol were gen-
erated by site-directed mutagenesis. Full oligonucleotide se-
quences are available from the authors on request. PIP* cor-
responds to the FF708–709AA mutation in the Polsequence.
DEAD Pol harbors a DE115–116AA mutation within the
catalytic domain.
Fluorescence microscopy
MRC5 cells grown on glass coverslips were transfected
using the jetPEI reagent according to the manufacturer’s
protocol (Polyplus). Cells were UV-irradiated at 8 J/m2
24 h after transfection and were processed after 8 h.
Cells were washed twice with phosphate buffered saline
(PBS) and treated for 5 min with CSK 100 buffer (100-
mM NaCl, 300-mM sucrose, 3-mM MgCl2, 10-mM Pipes
pH6.8, 1-mM EGTA) supplemented with 0.2% Triton-
X100 and a protease inhibitor cocktail (Complete, Roche).
Cells were washed and then fixed in 4% formaldehyde in
PBS and mounted onto slides using Fluorescent mounting
medium (SouthernBiotech). Slides were analyzed on a Le-
ica DMRA2 microscope equipped with an Orca-ER CCD
camera (Hamamatsu) and the capture software OpenLab
4.1 (Improvision).
The proximity ligation assay (PLA) kit was purchased
from Sigma. Cells were washed twice with PBS and treated
for 5 min with ice-cold CSK 100 buffer (100-mM NaCl,
300-mM sucrose, 3-mM MgCl2, 10-mM Pipes pH6.8, 1-
mM EGTA) supplemented with 0.2% Triton-X100 and a
protease inhibitor cocktail (Complete, Roche) and fixed as
described above. The primary antibodies (1/600 rabbit anti-
Pol, H-300 Santa Cruz; 1/500 mouse anti-PCNA, PC10,
Santa Cruz; 1/300 goat anti-POLD2, sc-8800, Santa Cruz)
were incubated overnight at 4◦C. Secondary antibodies con-
jugated with the PLA-oligonucleotide probes were used
(Duolink II PLA probe anti-mouse PLUS, anti-rabbit MI-
NUS and anti-goat PLUS) according to the manufacturer’s
instructions.
Clonogenic assay
XPV cell lines expressing WT or mutant Pol from the
pcDNA vector were plated in triplicate in 10-cm dishes
(3000 cells per plate). The next day, cells were washed in
PBS and UV-irradiated at a dose of 8 J/m2 (254 nm). Caf-
feine (0.375 mM) was added to the culture medium and cells
were incubated for 10 days. The number of colonies was as-
sessed after fixation in 4% formaldehyde and crystal violet
staining.
Flow cytometry (FACS)
Cells were collected by trypsinization, washed in PGE (glu-
cose 1 g/l in PBS-1-mM ethylenediaminetetraacetic acid
(EDTA)) and fixed in 70% ethanol in PBS-Glucose-EDTA
(PGE) at 4◦C for 1 h. Cells were washed twice in PGE and
nuclear DNA was stained with propidium iodide (4 g/ml;
Sigma, St. Louis, MO, USA) in the presence of RNase A (10
g/ml; Invitrogen) for at least 30 min. Stained cells were
analyzed on a FACScalibur (Becton Dickinson, Franklin
Lakes, NJ, USA) using CellQuest software. Twenty to thirty
thousand cells gated as single cells were analyzed.
Two-hybrid analysis
Two-hybrid analysis was performed in Saccharomyces cere-
visiae AH109, as described previously (30). Construction of
plasmid pGBKT7 containing POLD2 sequence has been
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GGAGATGTTTTCTGAGCAGGCTGCC-3′ and 5′-TC
GACGGATCCCTCAGGGGCCCAGCCCCAG-3′. The
NcoI/BamHI fragment has been inserted in pGBKT7. Mu-
tations were generated by site-directed mutagenesis into
the Pol coding sequence cloned in pACT2 plasmid. Full
oligonucleotide sequences are available from the authors on
request.
Proteins
His-GST, His-GST-Pol393–511 and His-GST-
Pol393–511(F1*) were cloned into pETM-30 plasmid,
expressed in Escherichia coli BL21 (DE3) pLysS bacteria
and purified in one step by Nickel column chromatography.
Purified proteins were stocked in 50-mM NaPO4 (pH =
7.4), 300-mM Nacl and 10% glycerol containing buffer and
flash frozen in liquid nitrogen.
GST-Pol was purified as described previously (31).
For expressing GST-Flag-POLD2, the POLD2 gene was
cloned in fusion with glutathione S-transferase (GST) and
FLAG tag under the control of the S. cerevisiae galactose-
inducible phosphoglycerate promoter using the Gateway
cloning system (Invitrogen) to generate plasmid BIL2695.
GST-Flag-POLD2-expressed yeast cells were disrupted in
NTE buffer (20-mM Tris-HCl pH 7.5, 1-mM dithiotreitol,
0.01% Nonidet P-40, 10% glycerol, 1000-mM NaCl, 5-mM
EDTA and protease inhibitor mixture). After clarification
of the crude extract by centrifugation it was loaded onto
a Glutathione-Sepharose column. First, the column was
washed with buffer NTE followed by washing with buffer
NT (20-mM Tris-HCl pH 7.5, 1-mM dithiotreitol, 0.01%
Nonidet P-40, 10% glycerol, 100-mM NaCl). The GST-
Flag-POLD2 protein was eluted by Prescission protease
cleavage in buffer NT. The Flag-POLD2 containing frac-
tions was pooled and stored at –80◦C.
In vitro transcription/translation of full-length WT or
mutant Poland POLD2 was performed using a TnT Quick
coupled lysate system (Promega) according to the man-
ufacturer’s instructions. The expression vectors encoding
the full-length Pol (pGBKT7-Pol) or POLD2 (pIVEX
POLD2 without His-Tag) were added to the reaction mix-
ture and incubated for 90 min at 30◦C.
Pull-down assays
Purified GST or GST-Polproteins (1.5 g) were incubated
with Glutathione-Sepharose (GTH) beads for 45 min at
4◦C with FLAG-POLD2 (0.5 g) in binding buffer contain-
ing 40-mM Tris HCl, pH 7.5, 70-mM NaCl, 0.1-mM DTT,
0.01% NP40, 10% glycerol). Beads were washed three times
with the binding buffer and boiled. Elution fractions were
analyzed by 10% sodium dodecyl sulphate/polyacrylamide
gel electrophoresis (SDS/PAGE) followed by Coomassie
blue staining or immunoblotting using anti-Flag antibody.
Equal amounts (125 g) of His-GST, His-GST-
Pol393–511 or His-GST-Pol393–511(F1*) were immobilized
onto equal amounts (1.32 mg) of pre-washed Dynabeads
His-Tag isolation and pull down (Life Technologies).
Washed and pre-loaded beads were then mixed with 35 l
of the POLD2 TnT reactions in 0.75x Buffer 1 (Buffer 1:
3.25-mM NaPO4 pH = 7.4, 70-mM NaCl, 0.01% Tween20
complemented with complete mini EDTA-free proteases
inhibitors, Roche) and incubated for 1.5 h at 4◦C with
resuspension every 5 min. Beads were washed once with
100 l of Buffer 1, resuspended in 20 l of 2x SDS page
loading buffer and boiled for 10 min.
TLS assay
The construction of single-stranded plasmids containing ei-
ther a single Cyclobutane Pyrimidine Dimer (CPD) lesion
(pUCTT-CPD.ss) or a unique G-AAF adduct (pUC3G3-
AAF.ss) has been extensively described (32). Primer exten-
sion assays were performed as previously described (33).
Standard reactions (6.25 l) were performed using 10 fmol
of primed single-strand DNA and an XPV cell extract (20
g) supplemented with WT or mutated Pol (0.2 l of retic-
ulocyte lysates). The quantification of the levels of TLS was
determined using the ImageQuant TL software after phos-
phorimaging (GE Healthcare). The percentage of TLS was
calculated as the ratio of the intensity of the bands of non-
slipped TLS (TLS 0) or slipped TLS (TLS-1) to the sum of
the intensity of the TLS and L-1 bands.
Immunoblotting
Proteins were loaded onto 8 or 10% SDS/polyacrylamide
gels. After electrophoresis, separated proteins were trans-
ferred onto a PVDF membrane (Biorad) and probed with
antibodies against Pol (H300, sc-5592), Pol (A9, sc-1777),
POLD2 (C-20, sc-8800), c-Myc (9E10, sc-40) from Santa
Cruz Biotechnology or GST (G7781) from Sigma.
RESULTS AND DISCUSSION
DNA Pol interacts with POLD2, the Pol subunit B
Human Pol is a replicative DNA polymerase consisting
of four subunits (POLD1, POLD2, POLD3 and POLD4).
POLD2 serves as a scaffold for the assembly of Pol by in-
teracting simultaneously with all of the other three subunits.
Using a yeast two-hybrid assay (Y2H) we tested the abil-
ity of Pol fused to the GAL4-activation domain to inter-
act with each of the four Pol subunits fused to the GAL4-
DNA binding domain and found that only POLD2 inter-
acts with Pol. No growth was observed in strains express-
ing both the Pol and empty expression plasmids, confirm-
ing the specificity of the Pol/POLD2 interaction.
Further analysis using the same Y2H assay revealed that
the region of Pol spanning amino acids 393–511 was suf-
ficient for the binding to POLD2 (Figure 1A). In order to
identify key residues of Pol involved in the interaction with
POLD2, we performed an alanine scanning analysis of sev-
eral amino acid stretches (boxed in Figure 1B) within this
region (393–511). Among the selected sequences, only mu-
tation of the TSLESFF sequence in Pol strongly dimin-
ishes the interaction with POLD2. Further mutational anal-
ysis within the TSLESFF stretch revealed that the FF mo-
tif (FF483–484, designated F1) within this region is essen-
tial for the binding to POLD2 (Supplementary Figure S1A
and Figure 1C). The direct interaction of Pol with POLD2
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Figure 1. Pol interacts with the POLD2 subunit of Pol. (A) Pol full length or truncation mutants and POLD2 proteins were expressed in the yeast
strain AH109 as a transcription activation domain fusion protein (in pACT2) and a DNA binding domain fusion protein (in pGBKT7), respectively. Yeast
transformants expressing both Pol and POLD2 fusion proteins are selected on double drop out medium (-W-L). Positive interactions are indicated by
growth on quadruple drop out medium (-W-L-A-H). (B) Minimum amino acid sequence of the Pol region that interacts with POLD2. Residues that were
mutated to alanine in the full-length Pol coding sequence and tested for their interaction with POLD2 are boxed. (C) Wild type and FF483–484AA (Pol
F1*) of full-length Pol were examined for the interaction with POLD2. (D) Association of POLD2 with Pol in vitro. Left panel: physical interaction
between the purified human DNA polymerase  and the POLD2 subunit of DNA polymerase . GST pull-down experiment was carried out using Flag-
POLD2 and GST-Pol or GST followed by immobilization on GTH beads. The bound proteins were analyzed by immunoblotting or Coomassie blue
staining. Right panel: selective binding of POLD2 with His-GST-Pol393–511. Pull-down experiments were carried out using in vitro translated POLD2, His-
GST, His-GST-Pol393–511 or His-GST-Pol393–511 (F1*) followed by immobilization on IMAC magnetic beads. Input and bound proteins were analyzed
by Coomassie blue staining or immunoblotting. Inputs correspond to 1/10th the protein amount used for pull-down.
confirmed using pull-down assays (Figure 1D). Both full-
length Pol1–713 and Pol393–511 fragment interact in vitro
with POLD2, while the mutated F1 version of Pol393–511
looses this ability.
Together, these results show that Pol binds to POLD2
via the fragment spanning amino acids 393–511 and that
the integrity of the F1 motif within this sequence is essential
for the Pol/POLD2 interaction. No interaction of POLD2
with Pol and Pol was detected by the Y2H assay (Sup-
plementary Figure S1B), suggesting that POLD2 specifi-
cally interacts with Pol, which thus may play a unique role
within the replication complex in higher eukaryotes.
The F1 motif of Pol contributes to lesion bypass in vitro
Using single-stranded monomodified plasmids, we have
previously shown (33,34) that in cell-free extracts, TLS
opposite an N-2-acetylaminofluorene guanine adduct (G-
AAF) or a cis-syn cyclobutane thymine dimer (TT-CPD)
is dependent on a catalytically active Pol. Even though
the primer extension assay employs an ssDNA template, we
demonstrated that it recapitulates the successive DNA poly-
merase switches that are necessary to promote TLS. In this
assay, the radiolabeled primer located 91 nucleotides away
from the lesion site is extended in a Pol-dependent manner
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Figure 2. Wild-type or mutant Pol displays the same catalytic activ-
ities. Time course of DNA synthesis catalyzed by wild-type (WT) or
mutant Pol using a primed single-stranded template (pUC118.ss). Up-
per panel: DNA products were subjected to electrophoresis on a 20%
polyacrylamide–7-M urea denaturing gel. Lower panel: immunoblot of the
different forms of Pol produced in rabbit reticulocytes lysates, using an
anti-myc antibody.
established that PCNA as well as the PIP and UBZ domains
of Pol that mediate the interaction with PCNA and Ubiq-
uitin, respectively, both contribute to the TLS reaction (34).
Besides the PIP and UBZ domains, the F1 motif has pre-
viously been shown to be involved in the interaction be-
tween Poland Rev1 in Y2H (35) together with a second FF
motif located downstream in the sequence (FF531–532, des-
ignated F2). However, recent reports (14,36) demonstrated
that the specific intermolecular interactions between Pol
and Rev1 more specifically involved the F2 motif as part
of the Rev1-interacting motif conserved between Pol, Pol
and Pol (RIM: FFxxK). To investigate the roles of these
FF motifs in the TLS activity of Pol, we expressed the WT
and mutant F1, F2 and PIP proteins (designated F1*, F2*
and PIP*), or combinations of them, in rabbit reticulocyte
lysates. In order to verify that the catalytic activities of these
proteins were equivalent, we tested their primer extension
efficiencies on undamaged DNA templates (Figure 2). We
then tested the ability of these proteins to complement an
XPV cell extract for the bypass of a G-AAF adduct and a
TT-CPD lesion (Figure 3A). Note that a single XPV extract
is used for different experiments, making the TLS efficiency
among the various forms of Pol readily comparable.
When the AAF adduct is located at the third guanine
of the 5′-GGG-3′ target sequence, the bypass catalyzed by
Polpredominantly induces a -1 frameshift mutation (TLS-
1) (33,37). Figure 3B shows that the Pol F1* and F1*F2*
mutant polymerases are clearly unable to complement the
XPV cell extracts to generate the Pol-specific TLS-1 prod-
uct, whereas a mutation of the F2 motif has no effect.
Consistently with previous data, the bypass across the G-
AAF adduct is strictly dependent on the PIP motif of Pol
(34). Similarly, the TT-CPD bypass efficiency of the comple-
mented extract has been tested (Figure 3C). As compared
to the reaction catalyzed by the WT enzyme, complemen-
tation of the XPV extract with Pol F1* results, in a repro-
ducible manner, in an increased accumulation of L-1 prod-
uct, clearly indicating a defect of this mutant in the TT-CPD
bypass. This defect is further highlighted when the PIP* and
F1* mutations are combined. On the other hand, and as ob-
served for the G-AAF adduct, the F2* mutation (alone or in
combination with PIP*) does not affect the TT-CPD bypass
activity of Pol in this assay. Altogether, these results show
that the F2 motif of Pol, known to be involved in the inter-
action of Pol with Rev1, is not necessary for TLS in cellu-
lar extracts, suggesting that Rev1 does not play any role in
TLS through a TT-CPD lesion and a G-AAF adduct when
assayed in vitro. We confirmed this hypothesis by showing
that both WT and Rev1−/− cell extracts (38) display simi-
lar TLS efficiencies through G-AAF or TT-CPD (Supple-
mentary Figure S2). In agreement with this result, CPD by-
pass in vivo has also been shown to be Rev1 independent in
mouse cells (39).
We have previously shown that PCNA is monoubiq-
uitinated during the primer extension reaction catalyzed
by cell-free extracts (40). We hypothesize that the pres-
ence of monoubiquitinated PCNA (Ub-PCNA) at the
template/primer junction, thought to increase the resi-
dence time of Pol at the lesion site, could compensate
for the effect of the F1* mutation on TLS efficiency. To
test this hypothesis, extracts from XPV cells were depleted
of PCNA and then complemented with either a WT or a
non-ubiquitinable form of purified PCNA (K164R mutated
PCNA). As expected, endogenous PCNA and purified WT
PCNA, but not K164R PCNA, were monoubiquitinated
during the primer extension reaction (Supplementary Fig-
ure S3A). We observed that the efficiency of bypass is glob-
ally lower in PCNA complemented cell-free extracts as com-
pared to the non-treated extracts (compare Figure 3C and
Supplementary Figure S3B), presumably because the deple-
tion procedure alters some protein function. Nevertheless,
the bypass deficiency of WT or Pol F1* is barely affected
by the ubiquitination status of PCNA, arguing that the role
of the F1 motif differs from that of Ub-PCNA for the by-
pass of a TT-CPD lesion assayed in vitro (Supplementary
Figure S3B).
The F1 motif of Pol is essential for cell survival and cell cycle
progression but not for foci formation after UV irradiation
Having shown that the F1 motif of Pol is required for its
interaction with POLD2 as well as for TLS in vitro, we
sought to determine the role of this motif in UV-induced
DNA damage tolerance in cellulo. XPV cell lines express-
ing either WT or mutated Pol were stably established, and
clones that express levels of Pol similar to the endoge-
nous level of Pol in normal immortalized MRC5 fibrob-
lasts were selected (Figure 4A). The UV survival of two in-
dependent cell lines expressing the Pol F1* is lower than
that of cell lines expressing WT Pol (Figure 4B). A previ-
ous report (41) showed that a mouse Pol mutated in the
F1 motif (FF482–483AA) fully corrects the UV sensitivity of
the parental XP-V cells to the level of WT cells. In this
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Figure 3. The F1 motif of Pol contributes to TLS in vitro through an AAF adduct and a TT-CPD lesion. (A) Outline of the experiment and diagram of
the modified plasmids. The length of the strand produced upon elongation of the [32P]-labeled primer, up to the lesion site, is indicated. nts : nucleotides.
(B) TLS efficiency through a G-AAF adduct located on the third guanine of a run of 3G. Monomodified DNA substrates (10 fmol) were incubated 20
min at 37◦C in the presence of XPV cell-free extracts (20 g) complemented with an equal amount (0.2 l) of different forms of Pol produced in vitro.
Samples were analyzed by electrophoresis through an 8% denaturing polyacrylamide gel. Product L-1 is generated when synthesis is blocked one nucleotide
before the lesion. TLS0 and TLS-1 are TLS products through an AAF adduct. Below the gel: immunoblot of the different forms of Pol produced in rabbit
reticulocytes lysates added to the reactions. (C) TLS efficiency through a TT-CPD lesion. Upper panel: monomodified DNA substrates (10 fmol) were
incubated 10 min at 37◦C in the presence of various amounts (0.33, 0.25 and 0.125 l) of either Pol wild-type (WT) or Pol mutant (Pol F1*) mixed with
XPV cell-free extracts (20 g). Below the gel: immunoblot of the different forms of Pol produced in rabbit reticulocytes lysates added to the reactions.
Lower panel: monomodified DNA substrates (10 fmol) were incubated 10 min at 37◦C in the presence of XPV cell-free extracts (20 g) complemented
with the same amount (0.2 l) of different forms of Pol produced in vitro. Below the gel: immunoblot of the different forms of Pol produced in rabbit
reticulocytes lysates and present in the reactions. Right panel: quantitative analysis of TLS efficiency with the different versions of Pol. Error bars denote
the standard deviation (SD) of at least two experiments performed with independent Pol samples (0.2 l).
(more than 5-fold over the endogenous level). Such high-
expression levels make fine regulation mechanisms dispens-
able as already shown for mutations in PIP or UBZ domains
of Pol (34,42). As observed in vitro, the effect of the F1 mu-
tation on cell survival is highly strengthened when F1* is
coupled to PIP*. Indeed, cells expressing the Pol F1*PIP*
double mutant are shown to be much more sensitive to UV
irradiation than those expressing either the Pol F1* or
PIP* single mutants. The same marked decrease in UV sur-
vival of double mutants compared to single mutants has al-
ready been described for cells harboring Pol UBZ*PIP*
and Pol S601APIP* (25,26,34,42).
As shown in Figure 4C, all cell lines tested displayed a
similar cell cycle distribution before UV irradiation. How-
ever, cells expressing WT or single mutant Pol showed a
significant blockage in S/G2 phases 24 h after UV irradi-
ation, in agreement with other studies (26). Remarkably,
cells expressing Pol F1*PIP* exhibit a phenotype similar
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Figure 4. The F1 and the PIP motifs of Pol both contribute to cell survival and cell cycle progression following UV irradiation. (A) Immunoblots
showing the expression of ectopic Pol versions in the different XPV-complemented cell lines. POLD1 was used as a loading control. The values under
the immunoblot represent the ratio of the intensity of Pol to POLD1 bands, relative to MRC5. (B) Clonogenic survival assay with XPV-derived cell lines
expressing Pol wild type or mutant following UV irradiation (8 J/m2) and growth in 0.375-mM caffeine-containing medium (EV: empty vector). Error
bars represent SD from at least three independent experiments. (C) Cell cycle profiles of XPV cells complemented with the indicated wild-type and mutant
forms of Pol determined by flow cytometry after DNA staining with propidium iodide. (D) Representative images of CSK-extracted nuclei from MRC5
cells cotransfected with the indicated plasmids and UV-irradiated (8 J/m2). Scale bar = 10 m. Representative images of one of the three independent
PLA assays for Pol/POLD2 (E) or Pol/PCNA (F) interactions. XPV cells complemented with the indicated wild-type and mutant forms of Pol were
either non-treated or UV-irradiated (20 J/m2) and processed after 6 h. CSK-extracted nuclei were labeled with DAPI (blue). PLA signals were observed as
white dots. The percentage of positive cells (containing at least four fluorescent spots) was scored (more than 450 cells were examined for each condition
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We compared the efficiency of replication foci formation
of WT and mutant Pol. For that purpose, we transiently
co-expressed WT ECFP-Pol and either WT or mutated
EYFP-Pol in human fibroblasts (MRC5). We observed a
nearly perfect colocalization of ECFP and EYFP signals
(Figure 4D) in cells expressing WT ECFP-Pol and EYFP-
Pol F1* 8 h after UVC exposure (8 J/m2). In contrast, a
mutation of the PIP motif abrogates the relocalization of
Pol in foci (Figure 4D), as already reported (42). This re-
sult indicates that the mutation of the F1 motif of Pol does
not alter the function of PIP domain, clearly indicating that
the two domains are required for separate functions of Pol.
Finally, we used the PLA to investigate the Pol/POLD2
interaction in XPV cells stably expressing WT or mutant
Polat physiological levels. While the interaction signal was
barely detectable in the chromatin of non-irradiated cells ex-
pressing WT Pol, a strong positive signal is observed 6 h
after UV irradiation (20 J/m2). This interaction signal be-
tween Pol and POLD2 is abolished in UV-irradiated cells
stably expressing Pol F1*, showing that, when Pol is not
overexpressed, F1 motif is required to maintain Pol and
POLD2 in close proximity within the replication complex.
To further analyze the role of the F1 motif in the stabiliza-
tion of Pol within replication complexes, we used the PLA
assay to analyze Pol/PCNA interaction (Figure 4F). For
both cells expressing either Pol WT or Pol F1*, the frac-
tion of positive cells increases similarly (2.5–2.9-fold) upon
UV irradiation, indicating that the F1 motif mutation does
not affect the recruitment of Pol. However, the interaction
signal between Pol and PCNA is systematically reduced in
cells expressing Pol F1*, as compared to cells expressing
Pol WT, confirming that F1 motif contributes to the sta-
bility of Pol within the replication complexes.
Clearly, the assay detects more Pol/PCNA than
Pol/POLD2 interactions in cells expressing Pol WT or
Pol F1*. Different hypotheses, or combinations of them,
may explain this difference. First, the quality of the antibod-
ies used may largely impact the signal-to-noise ratio. Sec-
ond, the POLD2/Pol interaction may be more transient
than the PCNA/Pol one. Finally, it is conceivable that the
POLD2/Pol interaction only occurs in a fraction of repli-
cation complexes.
CONCLUSION
Using both in vitro and in vivo approaches, we show in this
work that the F1 motif of Pol contributes to generate a
fully functional Pol. Furthermore, the double F1* PIP*
mutation has a much more dramatic effect than either sin-
gle mutation on the efficiency of TLS in vitro across a T-T
CPD lesion and on the survival of UV-irradiated cells. In
agreement with the survival data, the cells expressing Pol
F1*PIP* were severely blocked in S phase 24 h after UV
irradiation, similarly to XPV cells.
These defects indicate that F1 and PIP motifs differen-
tially contribute to the full activity of Pol. It has previ-
ously been observed that the UBZ domain contributes to
the retention of Pol at sites of stalled replication forks. As
a consequence, a Pol PIP*UBZ* double mutant failed to
rescue the UV sensitivity of XPV cells (34,42). Here we pro-
vide evidence that the F1 motif is additionally required for
efficient TLS in vitro, even in the presence of Ub-PCNA.
Moreover, while the F1 motif is not necessary for Pol foci
formation it nevertheless contributes to a great extent to UV
survival. This result indicates that the F1 motif plays an es-
sential role in TLS, which is not interchangeable with that of
Pol/PCNA or Pol/Ub interactions. Pol/POLD2 inter-
action via the F1 motif may provide a complementary an-
chor point facilitating either Pol integration into the repli-
some complex or its access to the template/primer junction
in a productive conformation.
Human Pol, the major lagging strand DNA polymerase,
is a heterotetramer composed of POLD1, POLD2, POLD3
and POLD4 subunits. This DNA polymerase is also likely
responsible for filling the lesion-induced post replicative
gaps, although this remains to be established. It is interest-
ing to note that the POLD4 subunit, which binds to both
POLD1 and POLD2, is degraded in response to DNA dam-
age (for a review see (43)). This observation led to the pro-
posal of a working model for the Pol/Polswitching mech-
anism on PCNA (44). In this model, when Pol encounters a
DNA damage, loss of POLD4 results in the disengagement
of POLD1 from the primer terminus, which becomes acces-
sible for Pol. Determining whether the F1 motif is required
for TLS at stalled replication forks to fill post-replicative
gaps (in a situation where POLD4 is absent from Pol) or
at processive ongoing replication forks (when POLD4 is
present) may help to decipher the molecular basis of TLS
regulation. For what concerns the lesions encountered dur-
ing processive leading strand DNA synthesis, the mecha-
nisms of Pol access to the DNA substrate remains to be
investigated.
In conclusion, our work provides evidences for a direct
interaction between Pol and POLD2 mediated by the F1
motif of the TLS polymerase and for a major role of this
motif in both TLS in vitro and UV survival of human cells.
Given the recent findings that POLD2 and POLD3 subunits
of Pol are functional components of Pol (15–17), we con-
sider that the Pol/POLD2 interaction described here may
also be involved in the switch between these two TLS poly-
merases when they are involved together in the bypass of
specific lesions (45,46).
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versité de Strasbourg and Ligue Régionale contre le Cancer.






/nar/article/43/4/2116/2411616 by guest on 20 Septem
ber 2021
2124 Nucleic Acids Research, 2015, Vol. 43, No. 4
REFERENCES
1. Hoege,C., Pfander,B., Moldovan,G.L., Pyrowolakis,G. and Jentsch,S.
(2002) RAD6-dependent DNA repair is linked to modification of
PCNA by ubiquitin and SUMO. Nature, 419, 135–141.
2. Stelter,P. and Ulrich,H.D. (2003) Control of spontaneous and
damage-induced mutagenesis by SUMO and ubiquitin conjugation.
Nature, 425, 188–191.
3. Watanabe,K., Tateishi,S., Kawasuji,M., Tsurimoto,T., Inoue,H. and
Yamaizumi,M. (2004) Rad18 guides poleta to replication stalling sites
through physical interaction and PCNA monoubiquitination. EMBO
J., 23, 3886–3896.
4. Kannouche,P.L., Wing,J. and Lehmann,A.R. (2004) Interaction of
human DNA polymerase eta with monoubiquitinated PCNA: a
possible mechanism for the polymerase switch in response to DNA
damage. Mol. Cell. Biol., 14, 491–500.
5. Bienko,M., Green,C.M., Crosetto,N., Rudolf,F., Zapart,G., Coull,B.,
Kannouche,P., Wider,G., Peter,M., Lehmann,A.R. et al. (2005)
Ubiquitin-binding domains in Y-family polymerases regulate
translesion synthesis. Science, 310, 1821–1824.
6. Guo,C., Tang,T.S., Bienko,M., Parker,J.L., Bielen,A.B., Sonoda,E.,
Takeda,S., Ulrich,H.D., Dikic,I. and Friedberg,E.C. (2006)
Ubiquitin-binding motifs in REV1 protein are required for its role in
the tolerance of DNA damage. Mol. Cell, 26, 8892–8900.
7. Plosky,B.S., Vidal,A.E., Fernandez de Henestrosa,A.R.,
McLenigan,M.P., McDonald,J.P., Mead,S. and Woodgate,R. (2006)
Controlling the subcellular localization of DNA polymerases iota
and eta via interactions with ubiquitin. EMBO J., 25, 2847–2855.
8. Bi,X., Barkley,L.R., Slater,D.M., Tateishi,S., Yamaizumi,M.,
Ohmori,H. and Vaziri,C. (2006) Rad18 regulates DNA polymerase
kappa and is required for recovery from S-phase checkpoint-mediated
arrest. Mol. Cell. Biol., 26, 3527–3540.
9. Sabbioneda,S., Gourdin,A.M., Green,C.M., Zotter,A.,
Giglia-Mari,G., Houtsmuller,A., Vermeulen,W. and Lehmann,A.R.
(2008) Effect of proliferating cell nuclear antigen ubiquitination and
chromatin structure on the dynamic properties of the Y-family DNA
polymerases. Mol. Biol. Cell, 19, 5193–5202.
10. Johnson,R.E., Washington,M.T., Haracska,L., Prakash,S. and
Prakash,L. (2000) Eukaryotic polymerases iota and zeta act
sequentially to bypass DNA lesions. Nature, 406, 1015–1019.
11. Prakash,S. and Prakash,L. (2002) Translesion DNA synthesis in
eukaryotes: a one- or two-polymerase affair. Genes Dev., 16,
1872–1883.
12. Livneh,Z., Ziv,O. and Shachar,S. (2010) Multiple two-polymerase
mechanisms in mammalian translesion DNA synthesis. Cell Cycle, 9,
729–735.
13. Wojtaszek,J., Lee,C.J., D’Souza,S., Minesinger,B., Kim,H.,
D’Andrea,A.D., Walker,G.C. and Zhou,P. (2012) Structural basis of
Rev1-mediated assembly of a quaternary vertebrate translesion
polymerase complex consisting of Rev1, heterodimeric polymerase
(Pol)  , and Pol . J. Biol. Chem., 287, 33836–33846.
14. Liu,D., Ryu,K.S., Ko,J., Sun,D., Lim,K., Lee,J.O., Hwang,J.M.,
Lee,Z.W. and Choi,B.S. (2013) Insights into the regulation of human
Rev1 for translesion synthesis polymerases revealed by the structural
studies on its polymerase-interacting domain. J. Mol. Cell Biol., 5,
204–206.
15. Johnson,R.E., Prakash,L. and Prakash,S. (2012) Pol31 and Pol32
subunits of yeast DNA polymerase delta are also essential subunits of
DNA polymerase zeta. Proc. Natl. Acad. Sci. U.S.A., 109,
12455–12460.
16. Baranovskiy,A.G., Lada,A.G., Siebler,H.M., Zhang,Y., Pavlov,Y.
and Tahirov,T.H. (2012) DNA polymerase delta and zeta switch by
sharing accessory subunits of DNA polymerase delta. J. Biol. Chem.,
287, 17281–17287.
17. Makarova,A.V., Stodola,J.L. and Burgers,P.M. (2012) A four-subunit
DNA polymerase zeta complex containing Pol delta accessory
subunits is essential for PCNA-mediated mutagenesis. Nucleic Acids
Res., 40, 11618–11626.
18. Daraba,A., Gali,V.K., Halmai,M., Haracska,L. and Unk,I. (2014)
Def1 promotes the degradation of Pol3 for polymerase exchange to
occur during DNA-damage–induced mutagenesis in Saccharomyces
cerevisiae. PLoS Biol., 12, e1001771.
19. Johnson,R.E., Prakash,S. and Prakash,L. (1999) Efficient bypass of a
thymine-thymine dimer by yeast DNA polymerase, Poleta. Science,
283, 1001–1004.
20. Masutani,C., Kusumoto,R., Iwai,S. and Hanaoka,F. (2000)
Mechanisms of accurate translesion synthesis by human DNA
polymerase eta. EMBO J., 19, 3100–3109.
21. McCulloch,S.D., Kokoska,R.J., Masutani,C., Iwai,S., Hanaoka,F.
and Kunkel,T.A. (2004) Preferential cis-syn thymine dimer bypass by
DNA polymerase eta occurs with biased fidelity. Nature, 428, 97–100.
22. Shachar,S., Ziv,O., Avkin,S., Adar,S., Wittschieben,J., Reissner,T.,
Chaney,S., Friedberg,E.C., Wang,Z., Carell,T. et al. (2009)
Two-polymerase mechanisms dictate error-free and error-prone
translesion DNA synthesis in mammals. EMBO J., 28, 383–393.
23. Yoon,J.H., Prakash,L. and Prakash,S. (2009) Highly error-free role of
DNA polymerase eta in the replicative bypass of UV-induced
pyrimidine dimers in mouse and human cells. Proc. Natl. Acad. Sci.
U.S.A., 106, 18219–18224.
24. Haracska,L., Johnson,R.E., Unk,I., Phillips,B., Hurwitz,J.,
Prakash,L. and Prakash,S. (2001) Physical and functional
interactions of human DNA polymerase eta with PCNA. Mol. Cell.
Biol., 21, 7199–7206.
25. Bienko,M., Green,C.M., Sabbioneda,S., Crosetto,N., Matic,I.,
Hibbert,R.G., Begovic,T., Niimi,A., Mann,M., Lehmann,A.R. et al.
(2010) Regulation of translesion synthesis DNA polymerase eta by
monoubiquitination. Mol. Cell, 37, 396–407.
26. Gohler,T., Sabbioneda,S., Green,C.M. and Lehmann,A.R. (2011)
ATR-mediated phosphorylation of DNA polymerase eta is needed
for efficient recovery from UV damage. J. Cell Biol., 192, 219–227.
27. Chen,Y.W., Cleaver,J.E., Hatahet,Z., Honkanen,R.E., Chang,J.Y.,
Yen,Y. and Chou,K.M. (2008) Human DNA polymerase eta activity
and translocation is regulated by phosphorylation. Proc. Natl. Acad.
Sci. U.S.A., 105, 16578–16583.
28. Huschtscha,L.I. and Holliday,R. (1983) Limited and unlimited
growth of SV40-transformed cells from human diploid MRC-5
fibroblasts. J. Cell Sci., 63, 77–99.
29. Masutani,C., Kusumoto,R., Yamada,A., Dohmae,N., Yokoi,M.,
Yuasa,M., Araki,M., Iwai,S., Takio,K. and Hanaoka,F. (1999) The
XPV (xeroderma pigmentosum variant) gene encodes human DNA
polymerase eta. Nature, 399, 700–704.
30. Tissier,A., Kannouche,P., Reck,M.P., Lehmann,A.R., Fuchs,R.P. and
Cordonnier,A. (2004) Co-localization in replication foci and
interaction of human Y-family members, DNA polymerase pol eta
and REVl protein. DNA Repair (Amst.), 3, 1503–1514.
31. Sebesta,M., Burkovics,P., Juhasz,S., Zhang,S., Szabo,J.E., Lee,M.Y.,
Haracska,L. and Krejci,L. (2013) Role of PCNA and TLS
polymerases in D-loop extension during homologous recombination
in humans. DNA Repair (Amst.), 12, 691–698.
32. Napolitano,R.L. and Fuchs,R.P. (1997) New strategy for the
construction of single-stranded plasmids with single mutagenic
lesions. Chem. Res. Toxicol., 10, 667–671.
33. Cordonnier,A.M., Lehmann,A.R. and Fuchs,R.P. (1999) Impaired
translesion synthesis in xeroderma pigmentosum variant extracts.
Mol. Cell. Biol., 19, 2206–2211.
34. Schmutz,V., Janel-Bintz,R., Wagner,J., Biard,D., Shiomi,N.,
Fuchs,R.P. and Cordonnier,A.M. (2010) Role of the
ubiquitin-binding domain of Poleta in Rad18-independent
translesion DNA synthesis in human cell extracts. Nucleic Acids Res.,
38, 6456–6465.
35. Ohashi,E., Hanafusa,T., Kamei,K., Song,I., Tomida,J.,
Hashimoto,H., Vaziri,C. and Ohmori,H. (2009) Identification of a
novel REV1-interacting motif necessary for DNA polymerase kappa
function. Genes Cells, 14, 101–111.
36. Pozhidaeva,A., Pustovalova,Y., D’Souza,S., Bezsonova,I.,
Walker,G.C. and Korzhnev,D.M. (2012) NMR structure and
dynamics of the C-terminal domain from human Rev1 and its
complex with Rev1 interacting region of DNA polymerase eta.
Biochemistry, 51, 5506–5520.
37. Janel-Bintz,R., Wagner,J., Haracska,L., Mah-Becherel,M.C.,
Bichara,M., Fuchs,R.P. and Cordonnier,A.M. (2012) Evidence for a
Rad18-independent frameshift mutagenesis pathway in human
cell-free extracts. PLoS One, 7, e36004.
38. Jansen,J.G., Langerak,P., Tsaalbi-Shtylik,A., van den Berk,P.,






/nar/article/43/4/2116/2411616 by guest on 20 Septem
ber 2021
Nucleic Acids Research, 2015, Vol. 43, No. 4 2125
transversions in hypermutating immunoglobulin genes in
Rev1-deficient mice. J. Exp. Med., 203, 319–323.
39. Temviriyanukul,P., van Hees-Stuivenberg,S., Delbos,F., Jacobs,H., de
Wind,N. and Jansen,J.G. (2012) Temporally distinct translesion
synthesis pathways for ultraviolet light-induced photoproducts in the
mammalian genome. DNA Repair (Amst.), 11, 550–558.
40. Schmutz,V., Wagner,J., Janel-Bintz,R., Fuchs,R.P. and
Cordonnier,A.M. (2007) Requirements for PCNA
monoubiquitination in human cell-free extracts. DNA Repair
(Amst.), 6, 1726–1731.
41. Akagi,J., Masutani,C., Kataoka,Y., Kan,T., Ohashi,E., Mori,T.,
Ohmori,H. and Hanaoka,F. (2009) Interaction with DNA
polymerase eta is required for nuclear accumulation of REV1 and
suppression of spontaneous mutations in human cells. DNA Repair
(Amst.), 8, 585–599.
42. Despras,E., Delrieu,N., Garandeau,C., Ahmed-Seghir,S. and
Kannouche,P.L. (2012) Regulation of the specialized DNA
polymerase eta: revisiting the biological relevance of its PCNA- and
ubiquitin-binding motifs. Environ. Mol. Mutagen., 53, 752–765.
43. Lee,M.Y., Zhang,S., Lin,S.H., Wang,X., Darzynkiewicz,Z., Zhang,Z.
and Lee,E.Y. (2014) The tail that wags the dog: p12, the smallest
subunit of DNA polymerase delta, is degraded by ubiquitin ligases in
response to DNA damage and during cell cycle progression. Cell
Cycle, 13, 23–31.
44. Lee,M.Y., Zhang,S., Lin,S.H., Chea,J., Wang,X., LeRoy,C., Wong,A.,
Zhang,Z. and Lee,E.Y. (2012) Regulation of human DNA
polymerase delta in the cellular responses to DNA damage. Environ.
Mol. Mutagen., 53, 683–698.
45. Hirota,K., Sonoda,E., Kawamoto,T., Motegi,A., Masutani,C.,
Hanaoka,F., Szuts,D., Iwai,S., Sale,J.E., Lehmann,A. et al. (2010)
Simultaneous disruption of two DNA polymerases, Poleta and
Polzeta, in Avian DT40 cells unmasks the role of Poleta in cellular
response to various DNA lesions. PLoS Genet., 6, e1001151.
46. Lee,Y.S., Gregory,M.T. and Yang,W. (2014) Human Pol zeta purified
with accessory subunits is active in translesion DNA synthesis and







/nar/article/43/4/2116/2411616 by guest on 20 Septem
ber 2021
